BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 11400112)

  • 1. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Sugimoto K; Tai Y; Tokuda M
    Int J Cancer; 2001 Jul; 95(4):209-15. PubMed ID: 11400112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Tai Y; Sugimoto K; Hirao T; Tokuda M
    Clin Cancer Res; 2000 Nov; 6(11):4253-8. PubMed ID: 11106240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma.
    Zhang YY; Xu ZN; Wang JX; Wei DM; Pan XL
    Asian Pac J Cancer Prev; 2012; 13(5):2133-7. PubMed ID: 22901182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma.
    Ahmed RA; Shawky Ael-A; Hamed RH
    Pathol Oncol Res; 2014 Jul; 20(3):625-33. PubMed ID: 24470282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The overexpression of cyclin-dependent kinase (CDK) 2 in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Tai Y; Sugimoto K; Tokuda M
    Anticancer Res; 2001; 21(1A):103-8. PubMed ID: 11299721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma.
    Pignataro L; Pruneri G; Carboni N; Capaccio P; Cesana BM; Neri A; Buffa R
    J Clin Oncol; 1998 Sep; 16(9):3069-77. PubMed ID: 9738577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
    Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
    Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma.
    Matsumoto M; Furihata M; Ishikawa T; Ohtsuki Y; Ogoshi S
    Br J Cancer; 1999 Apr; 80(1-2):256-61. PubMed ID: 10390005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of cyclin A in laryngeal squamous cell carcinoma.
    Dong Y; Sui L; Watanabe Y; Sugimoto K; Tokuda M
    Anticancer Res; 2002; 22(1A):83-9. PubMed ID: 12017338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
    Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
    J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.
    Li L; Wang J; Gao L; Gong L
    Int J Clin Exp Pathol; 2015; 8(8):9232-9. PubMed ID: 26464671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase inhibitor p27 is related to cell proliferation and prognosis in laryngeal squamous cell carcinomas.
    Tamura N; Dong Y; Sui L; Tai Y; Sugimoto K; Nagahata S; Tokuda M
    J Laryngol Otol; 2001 May; 115(5):400-6. PubMed ID: 11410133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
    Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
    Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
    Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG
    Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
    Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications.
    Dong Y; Sui L; Watanabe Y; Sugimoto K; Tokuda M
    Oncol Rep; 2003; 10(2):321-5. PubMed ID: 12579266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator.
    Shih HC; Shiozawa T; Kato K; Imai T; Miyamoto T; Uchikawa J; Nikaido T; Konishi I
    Hum Pathol; 2003 May; 34(5):471-8. PubMed ID: 12792921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
    Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma.
    Dong Y; Sui L; Watanabe Y; Sugimoto K; Tokuda M
    Cancer Lett; 2002 Mar; 177(1):13-9. PubMed ID: 11809526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.